Switch to: Citations

References in:

Avoiding Gender Exploitation and Ethics Dumping in Research with Women

Cambridge Quarterly of Healthcare Ethics 29 (3):470-479 (2020)

Add references

You must login to add references.

Human Food Trial of a Transgenic Fruit.Jaci van Niekerk & Rachel Wynberg - 2017 - In Doris Schroeder, Julie Cook, François Hirsch, Solveig Fenet & Vasantha Muthuswamy (eds.), Ethics Dumping: Case Studies from North-South Research Collaborations. New York: Springer. pp. 91-98.details The research and developmentResearch and Development of any “new” agricultural crop created using genetic modification technologies, even if undertaken with the best of intentions, is accompanied by novel human health, environmental, social, economic and other risksRisks. To date, much of the research that has accompanied the release of genetically modified Genetically Modified crops has focused on the environmental and health impacts. Evidence has been inconclusive, however, with debates remaining highly divided and contested, and each “camp” presenting evidence to support its (...) position. (shrink) Download Export citation Bookmark 4 citations
Cervical Cancer Screening in India.Sandhya Srinivasan, Veena Johari & Amar Jesani - 2017 - In Doris Schroeder, Julie Cook, François Hirsch, Solveig Fenet & Vasantha Muthuswamy (eds.), Ethics Dumping: Case Studies from North-South Research Collaborations. New York: Springer. pp. 33-48.details Three clinical trials took place in India between 1998 and 2015 in Urban and Rural areas of Mumbai, Osmanabad and Dindigul. The trials aimed to determine whether trained health care workers could conduct cervical cancer screening in a Community using cheap methods of testing – primarily visual inspection with acetic acid – to reduce the incidence and mortality rate of cervical cancer. The clinical trials were conducted on approximately 374,000 Women, of whom about 141,000 were placed in the Control arm. (...) Download Export citation Bookmark 4 citations
Ethics Dumping: Case Studies from North-South Research Collaborations.Doris Schroeder, Julie Cook, François Hirsch, Solveig Fenet & Vasantha Muthuswamy (eds.) - 2017 - New York: Springer.details This open access book provides original, up-to-date case studies of “ethics dumping” that were largely facilitated by loopholes in the ethics governance of low and middle-income countries. It is instructive even to experienced researchers since it provides a voice to vulnerable populations from the fore mentioned countries. Ensuring the ethical conduct of North-South collaborations in research is a process fraught with difficulties. The background conditions under which such collaborations take place include extreme differentials in available income and power, as well (...) Download Export citation Bookmark 14 citations
Gender and Vulnerable Populations in Benefit Sharing: An Exploration of Conceptual and Contextual Points.Fatima Alvarez-Castillo, Julie Cook Lucas & Rosa Cordillera Castillo - 2009 - Cambridge Quarterly of Healthcare Ethics 18 (2):130.details Download Export citation Bookmark 1 citation
Vulnerability: Too Vague and Too Broad?Doris Schroeder & Eugenijus Gefenas - 2009 - Cambridge Quarterly of Healthcare Ethics 18 (2):113.details Imagine you are walking down a city street. It is windy and raining. Amidst the bustle you see a young woman. She sits under a railway bridge, hardly protected from the rain and holds a woolen hat containing a small number of coins. You can see that she trembles from the cold. Or imagine seeing an old woman walking in the street at dusk, clutching her bag with one hand and a walking stick with the other. A group of male (...) Download Export citation Bookmark 40 citations
Healthy Volunteers for Clinical Trials in Resource-Poor Settings: National Registries Can Address Ethical and Safety Concerns.Francois Bompart - 2019 - Cambridge Quarterly of Healthcare Ethics 28 (1):134-143.details Healthy Volunteers (HVs) who participate in clinical trials are a vulnerable group that deserves specific protection. We assessed the number and types of studies that involve HVs around the world and outline the methodological barriers to their analysis. We found that tens of thousands of HVs are involved every year in clinical trials in a large variety of countries and that the overwhelming majority of studies are not “first-in-human” but pharmacokinetic studies. The two cornerstones for both ethical and safe participation (...) Download Export citation Bookmark 1 citation

1